Kovack Advisors, Inc. Veru Inc. Transaction History
Kovack Advisors, Inc.
- $988 Million
- Q2 2025
A detailed history of Kovack Advisors, Inc. transactions in Veru Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 100,000 shares of VERU stock, worth $256,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$256,000
Previous $49,000
16.33%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VERU
# of Institutions
109Shares Held
42.4MCall Options Held
50.5KPut Options Held
824K-
Black Rock Inc. New York, NY7.65MShares$19.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.41MShares$16.4 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.91MShares$12.6 Million0.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$6.71 Million0.0% of portfolio
-
Ubs Group Ag1.65MShares$4.24 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $205M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....